Professor Andrew Protheroe

Professor. Andrew Protheroe is an Associate Professor of Uro-Oncology within the University of Oxford Department of Oncology at the Oxford Cancer and Haematology Centre. He is a highly experienced Consultant Medical Oncologist specialising in managing urological cancer (prostate, kidney, bladder and testicular cancer) at Oxford since 2001. He qualified from St Thomas's Hospital in London and after general medical training in London, trained in Oncology at St James's University Hospital in Leeds. His PhD was in tumour immunology and the research was based at Leeds and the National Cancer Institute in Amsterdam as an Honorary ICRF Clinical Research fellow funded by a Northern and Yorkshire research award.

Professor. Protheroe specialises in managing and overseeing patients with urological cancer providing specialised expert care to patients and their families covering all aspects of chemotherapy, hormonal therapy, immunotherapy, radium 223, growth inhibitors and novel therapies; giving plentiful options to give patients as many options as possible.

In addition to his other work, he is also one of the founding trustees for the urological cancer charity UCARE which supports research and awareness. He was also instrumental in setting up the kidney cancer support group (FROG), and helped to develop the prostate and bladder cancer support groups and set up initiatives to support men with testicular cancer.

It is clear from Professor Protheroe's work in both clinical practice, research and charity work that he is fully invested in the clinical care of his patients but also supporting their emotional wellbeing, giving them the best overall experience in their cancer journey.

• Immunotherapy
• Personalised medicine for urological cancers
• Gastroesophageal
• Head and neck oncology
• Chemotherapy
• Haemato-oncology
• Breast ultrasound

• Prostate Cancer
• Bladder Cancer
• Kidney Cancer
• Testicular Cancer